Omeros reported $-1.12 in EPS Earnings Per Share for its fiscal quarter ending in June of 2024.





Eps Change Date
Adma Biologics USD 0.16 0.03 Jun/2026
Alnylam Pharmaceuticals USD 16.26 14.42 Sep/2026
BioMarin Pharmaceutical USD 0.23 0.97 Sep/2026
Cytokinetics USD -1.37 0.13 Sep/2026
Gilead Sciences USD 2.55 9.3 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Insmed USD -0.46 0.4 Sep/2026
Knight Therapeutics CAD 0.13 0.22 Mar/2026
MacroGenics USD 0.31 0.89 Jun/2026
Omeros USD -1.12 0.37 Jun/2024
Pacira USD 0.7 0.03 Sep/2026
Pfizer USD 0.87 0.1 Sep/2026
Rockwell Medical USD 0.01 0.07 Jun/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
United Therapeutics USD 5.71 1.56 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026